Genentech Inc.

10/17/2025 | Press release | Distributed by Public on 10/17/2025 23:10

Genentech’s Phase III evERA Data Showed Giredestrant Significantly Improved Progression-Free Survival in People With ER-Positive Advanced Breast Cancer

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.
Genentech Inc. published this content on October 17, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 18, 2025 at 05:10 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]